Indirect Purchasers Certified In Wellbutrin Antitrust Suit

Law360, New York (August 15, 2011, 6:58 PM EDT) -- A Pennsylvania federal judge on Monday granted class certification to a group of indirect purchasers of Wellbutrin XL and its generic equivalent in a suit that accuses drugmakers Biovail Corp. and GlaxoSmithKline PLC of lodging baseless patent suits to delay the generic competition for the popular antidepressant.

U.S. District Judge Mary A. McLaughlin issued the order certifying the class of individuals who bought the drug in six U.S. states — California, Florida, Nevada, Tennessee, New York and Wisconsin. The certification follows a Thursday decision to grant class certification...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.